ArticleJournal of pharmacy & bioallied sciences2024
Nano Phosphorylated Pullulan-Integrated Carboxymethyl Chitosan Scaffold for Regeneration of the Pulp-Dentin Complex: An
Article in Journal of pharmacy & bioallied sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Engineered biomaterial-based scaffolds for dentin-pulp complex regeneration: applications and biological performance-a scoping review.Odontology · 2026Review
- Chitosan-Based Nanoparticles and Biomaterials for Pulp Capping and Regeneration: A Systematic Review with Quantitative and Evidence-Mapping Synthesis.Biomimetics (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To optimize a novel composite scaffold comprising of nano phosphorylated pullulan incorporated carboxymethyl chitosan (nPP-CMC) and to evaluate its cell viability and proliferation in human dental pulp stem cells (hDPSCs). Methodology: Nano phosphorylated pullulan (nPP) in concentrations of 200 mg, 400 mg, 600 mg, 800 mg, and 1 g was vortexed in 20 mL of distilled water, followed by 30 mins of ultrasonication for even dispersion. 1 g of CMC was added to each nPP mixture, blended for 1 hour to form a hydrogel, and freeze-dried for 18 hours at -20°C to yield nPP-CMC scaffolds in ratios of 1:5, 2:5, 3:5, 4:5, and 1:1. These scaffolds were stored at room temperature. The scaffolds were characterized using SEM-EDX, FT-IR, and XRD. The optimized nPP-CMC (group 1), CMC (group 2), and osteogenic medium (group 3) were tested for cell viability with hDPSCs using the MTT assay at 0, 7, 14, and 21 days. Results: Based on the results of MTT assay, the cell viability and proliferation of nPP-CMC scaffold was comparable to that of CMC in the tested time intervals of 7 and 14 days. The 4:5 nPP-CMC revealed a favourable pore size (60-180 μm) that was suitable for cell seeding and was chosen for further experiments. Cell viability/proliferation rates of hDPSCs loaded 4:5 HAnp- CMC at 21 Conclusion: Hence, within the limitations of this
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.